Abstract:The tumor microenvironment (TME) is crucial in cancer progression and immunotherapy response. Optical imaging techniques provide a noninvasive, real time method to analyze immune cells in the TME, helping predict and monitor immunotherapy outcomes. This review highlights advancements in optical imaging for TME immunotherapy and its potential in clinical trials and personalized cancer treatment. Background The tumor microenvironment (TME) plays a critical role in cancer progression and response to immunotherapy. Immunotherapy targeting the immune system has emerged as a promising treatment modality, but challenges in understanding the TME limit its efficacy. Optical imaging strategies offer noninvasive, real‐time insights into the interactions between immune cells and the TME. Objective This review assesses the progress of optical imaging technologies in monitoring immunotherapy within the TME and explores their potential applications in clinical trials and personalized cancer treatment. Methods This is a comprehensive literature review based on the advances in optical imaging modalities including fluorescence imaging (FLI), bioluminescence imaging (BLI), and photoacoustic imaging (PAI). These modalities were analyzed for their capacity to provide high‐resolution, real‐time imaging of immune cell dynamics, tumor vasculature, and other critical components of the TME. Results Optical imaging techniques have shown significant potential in tracking immune cell infiltration, assessing immune checkpoint inhibitors, and visualizing drug delivery within the TME. Technologies like FLI and BLI are pivotal in tracking immune responses in preclinical models, while PAI provides functional imaging with deeper tissue penetration. The integration of these modalities with immunotherapy holds promise for improving treatment monitoring and outcomes. Conclusion Optical imaging is a powerful tool for understanding the complexities of the TME and optimizing immunotherapy. Further advancements in imaging technologies, combined with nanomaterial‐based approaches, could pave the way for enhanced diagnostic accuracy and therapeutic efficacy in cancer treatment.

Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments

Molecular Imaging for Cancer Immunotherapy: Seeing is Believing

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Monitoring Immunotherapy With Optical Molecular Imaging

Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy

Molecular Immune Targeted Imaging of Tumor Microenvironment

NIR fluorescence imaging and treatment for cancer immunotherapy

Fluorescence Imaging of Tumor Immune Contexture in Immune Checkpoint Blockade Therapy.

Applications of Intravital Imaging in Cancer Immunotherapy

Optical image-guided cancer therapy.

Emerging Biomaterials Imaging Antitumor Immune Response

Advancing cancer immunotherapy through emerging intratumoral delivery and biomedical imaging technologies

Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy

Illuminating immunotherapy response via precision T cell-targeted PET imaging

Optical Imaging of in Vivo Adoptive T‐cell Therapy: State of the Art and Challenges

Optical Molecular Imaging for Tumor Detection and Image-Guided Surgery.

Visualizing the Tumor Microenvironment: Molecular Imaging Probes Target Extracellular Matrix, Vascular Networks, and Immunosuppressive Cells

Immunotherapy and the role of imaging

In vivo optical imaging of anti-tumor immune response

Imaging strategies for monitoring the immune response.

Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications